53 related articles for article (PubMed ID: 10201760)
1. Mutational analyses of candidate genes in human squamous cell carcinomas.
Petroianu A; Boson WL; Bale AE; Friedman E; De Marco L
Laryngoscope; 1999 Apr; 109(4):661-3. PubMed ID: 10201760
[TBL] [Abstract][Full Text] [Related]
2. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
3. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
5. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing].
Fang Q; Li X; Li J; Liang S
Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630
[TBL] [Abstract][Full Text] [Related]
6. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
7. Use of denaturing gradient gel blots to screen for point mutations in the factor VIII gene.
Laprise SL; Mak EK; Killoran KA; Layman LC; Gray MR
Hum Mutat; 1998; 12(6):393-402. PubMed ID: 9829908
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.
Kim YR; Oh JE; Kim MS; Kang MR; Park SW; Han JY; Eom HS; Yoo NJ; Lee SH
J Pathol; 2010 Mar; 220(4):446-51. PubMed ID: 19967722
[TBL] [Abstract][Full Text] [Related]
9. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of p53 mutation: analysis by direct sequencing and multisequence analysis.
Rozemuller EH; Kropveld A; Kreyveld E; Leppers FG; Scheidel KC; Slootweg PJ; Tilanus MG
Cancer Detect Prev; 2001; 25(2):109-16. PubMed ID: 11341345
[TBL] [Abstract][Full Text] [Related]
12. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
14. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
16. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
[TBL] [Abstract][Full Text] [Related]
17. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
Fukuda M; Nakatsuka T; Kusama K; Sakashita H
J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
[No Abstract] [Full Text] [Related]
18. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
19. Absence of ST7 gene alterations in human cancer.
Dong SM; Sidransky D
Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
[TBL] [Abstract][Full Text] [Related]
20. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
